Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.19 +0.00 (+0.00%)
As of: Oct 5, 2026 · 3:45 PM EDT

Drugs Made In America Acquisition (DMII) Total Current Liabilities (2024 - 2026)

Updated

Drugs Made In America Acquisition (DMII) reported Total Current Liabilities of $644,574 for Q2 2026.

Analysis

Drugs Made In America Acquisition (DMII) Total Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Drugs Made In America Acquisition posted Total Current Liabilities of $300,864, up 18.1% from FY2024.

  • By year, Total Current Liabilities came in at $254,783 in FY2024.
  • Five-year quarterly Total Current Liabilities spans a low of $254,783 in Q4 2024 and a high of $677,345 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 BlackRock 164.13 Bn 110.49 Bn - -
2 Spdr Gold Trust 133.82 Bn -424.18 Bn - -
3 Blackstone 84.08 Bn 79.01 Bn - -
4 Brookfield 82.97 Bn -82.41 Bn 4.47 Bn -
5 Kkr 81.05 Bn 47.53 Bn - -
6 Brookfield Asset Management 71.64 Bn 67.88 Bn - -
7 Apollo Global Management 65.67 Bn 3.35 Bn 10.56 Bn -
8 Wheaton Precious Metals 61.89 Bn 57.32 Bn 687.86 Mn 279.31 Mn
9 Franco Nevada 46.13 Bn 43.49 Bn 451.00 Mn 148.00 Mn
10 Drugs Made In America Acquisition 649.10 Mn 649.10 Mn - 644,574.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 644,574.00
Dec 31, 2025 300,864.00
Sep 30, 2025 677,345.00
Dec 31, 2024 254,783.00
API Access

Drugs Made In America Acquisition Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=DMII&period=max&api_key=YOUR_API_KEY